Publications Print Torres F, Shedd C, Kaza V, Bollineni S, Banga A, Mohanka MR, Ladikos N, Wijesinha M, Mahan LD, Lawrence A, Joerns J, Terada L, Timofte I. Outpatient management of Post-COVID syndrome - single center experience. Heart Lung. 2024 May 16; 67:137-143 [Epub ahead of print] View PubMed Narasimhan M, Muthukumar A, Sataranatarajan K, Mahimainathan L, Mahan L, Timofte I, Bollineni S, Joerns J, Zhang S, Gorman A, Banga A, Mohanka M, Torres F, Lawrence A, Thalachallour M, Kaza V. Crossroads between Autoimmunity and COVID-19 in Lung Transplant Recipients. Viruses. 2023 Oct 3; 15 (10) Epub 2023 Oct 03 View PubMed Mahan LD, Mohanka MR, Joerns J, Lawrence A, Bollineni S, Kaza V, Timofte I, La Hoz RM, Sorelle J, Terada LS, Kershaw CD, Torres F, Banga A. A Case Report of Breakthrough Infections With 2 SARS-CoV-2 Variants in a Lung Transplant Patient. Transplant Proc. 2022 Dec; 54 (10):2698-2701 Epub 2022 July 26 View PubMed Bollineni S, Mahan LD, Lawrence A, Joerns J, Timofte I, Torres F, Kaza V, La Hoz RM, SoRelle JA, Kershaw CD, Terada LS, Zhang S, Mohanka MR, Banga A. COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough Infections. Transplant Proc. 2022 Jul-Aug; 54 (6):1517-1523 Epub 2022 June 15 View PubMed Lawrence A, Lovin D, Mohanka MR, Joerns J, Bollineni S, Kaza V, Torres F, Murala J, Peltz M, Wait MA, Banga A. Diaphragmatic plication among lung transplant patients: A single-center experience. Clin Transplant. 2022 Jul; 36 (7):e14683 Epub 2022 May 03 View PubMed Joerns J, Bollineni S, Mahan LD, Mohanka MR, Lawrence A, Timofte I, Torres F, La Hoz RM, Zhang S, Kershaw CD, Kaza V, Terada LS, Banga A. High-dose Mycophenolate Use at Vaccination Is Independently Associated With Breakthrough COVID-19 Among Lung Transplant Patients. Transplantation 2022 May 1; 106 (5):e271-e274 Epub 2022 Mar 01 View PubMed Bollineni S, Mahan LD, Duncan P, Mohanka MR, Lawrence A, Joerns J, Timofte I, Torres F, La Hoz RM, Kershaw CD, Terada LS, Kaza V, Banga A. Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID-19. Transpl Infect Dis. 2022 Apr; 24 (2):e13784 Epub 2022 Jan 19 View PubMed Mohanka MR, Joerns J, Lawrence A, Bollineni S, Kaza V, Cheruku S, Leveno M, Chen C, Terada LS, Kershaw CD, Torres F, Peltz M, Wait MA, Hackmann AE, Banga A. ECMO Long Haulers: A Distinct Phenotype of COVID-19-Associated ARDS With Implications for Lung Transplant Candidacy. Transplantation. 2022 Apr 1; 106 (4):e202-e211 View PubMed Harris ZM, Sun Y, Joerns J, Clark B, Hu B, Korde A, Sharma L, Shin HJ, Manning EP, Placek L, Unutmaz D, Stanley G, Chun H, Sauler M, Rajagopalan G, Zhang X, Kang MJ, Koff JL. Epidermal Growth Factor Receptor Inhibition Is Protective in Hyperoxia-Induced Lung Injury. Oxid Med Cell Longev. 2022; 2022:9518592 Epub 2022 Sept 20 View PubMed Mahan LD, Lill I, Halverson Q, Mohanka MR, Lawrence A, Joerns J, Bollineni S, Kaza V, La Hoz RM, Zhang S, Kershaw CD, Terada LS, Torres F, Banga A. Post-infection pulmonary sequelae after COVID-19 among patients with lung transplantation. Transpl Infect Dis. 2021 Dec; 23 (6):e13739 Epub 2021 Oct 17 View PubMed Mohanka MR, Mahan LD, Joerns J, Lawrence A, Bollineni S, Kaza V, La Hoz RM, Kershaw CD, Terada LS, Torres F, Banga A. Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19. J Heart Lung Transplant. 2021 Sep; 40 (9):936-947 Epub 2021 May 18 View PubMed Mahan LD, Points A, Mohanka MR, Bollineni S, Joerns J, Kaza V, La Hoz RM, Gao A, Zhang S, Torres F, Banga A. Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection. Transpl Infect Dis. 2021 Aug; 23 (4):e13661 Epub 2021 June 22 View PubMed Mohanka M, Pinho DF, Garcia H, Kanade R, Bollineni S, Joerns J, Kaza V, Mathews D, Torres F, Zhang S, Banga A. Spectrum of findings on ventilation‒perfusion lung scintigraphy after lung transplantation and association with outcomes. J Heart Lung Transplant. 2021 May; 40 (5):377-386 Epub 2021 Jan 16 View PubMed Kaza V, Zhu C, Terada LS, Wang L, Torres F, Bollineni S, Mohanka M, Banga A, Joerns J, Mohanakumar T, Li QZ. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction. Hum Immunol. 2021 Jan; 82 (1):25-35 Epub 2020 Oct 28 View PubMed Mahan LD, Kanade R, Mohanka MR, Bollineni S, Joerns J, Kaza V, Torres F, La Hoz RM, Banga A. Characteristics and outcomes among patients with community-acquired respiratory virus infections during the first year after lung transplantation. Clin Transplant. 2021 Jan; 35 (1):e14140 Epub 2020 Nov 20 View PubMed Mohanka MR, Kanade R, Garcia H, Mahan L, Bollineni S, Mullins J, Joerns J, Kaza V, Torres F, Zhang S, Banga A. Significance of Best Spirometry in the First Year After Bilateral Lung Transplantation: Association With 3-Year Outcomes. Transplantation. 2020 Aug; 104 (8):1712-1719 View PubMed Kaza V, Zhu C, Feng L, Torres F, Bollineni S, Mohanka M, Banga A, Joerns J, Mohanakumar T, Terada LS, Li QZ. Pre-existing self-reactive IgA antibodies associated with primary graft dysfunction after lung transplantation. Transpl Immunol. 2020 Apr; 59:101271 Epub 2020 Jan 30 View PubMed Woll F, Mohanka M, Bollineni S, Joerns J, Kaza V, Torres F, Tanriover B, Banga A. Characteristics and Outcomes of Lung Transplant Candidates With Preexisting Renal Dysfunction. Transplant Proc. 2020 Jan-Feb; 52 (1):302-308 Epub 2020 Jan 08 View PubMed Kalinowski A, Galen BT, Ueki IF, Sun Y, Mulenos A, Osafo-Addo A, Clark B, Joerns J, Liu W, Nadel JA, Dela Cruz CS, Koff JL. Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium. Mucosal Immunol. 2018 May; 11 (3):958-967 Epub 2018 Feb 07 View PubMed PST-20564527 Home Publications